View Demonstration Videos

Play Video.

With Voice Instructions

The audio and visual instructions of Auvi‑Q guide patients through the injection process.

Play Video Download Video Embed Video
Play Video.

Without Voice Instructions

Patients may use the device without waiting for the voice instructions to guide them. Once the injection countdown has begun, however, they should not remove the device from their thigh until the voice prompt says, "Injection complete."

Play Video Download Video Embed Video
Play Video.

Patient Demo Video

Healthcare professionals can share this video with patients to help get them familiar with Auvi‑Q and how it works. The video includes a step‑by‑step demonstration.

Play Video Download Video Embed Video

NOTE: Auvi‑Q makes a distinct click and hiss sound when pressed against the outer thigh. This is normal and indicates that Auvi‑Q is working correctly. Patients should be advised not to pull Auvi‑Q away from the leg when they hear the click and hiss sound.

Epinephrine should be administered with caution to patients with hyperthyroidism, diabetes, elderly individuals, pregnant women, patients who have heart disease and patients who are on medications that may sensitize the heart to arrhythmias.

Terms & Conditions

The following terms of use apply to your use of the Auvi-Q™ (epinephrine injection, USP) video(s) ("Assets").

1. Sanofi US, on behalf of itself and its affiliates, hereby grants to you ("You") a non‑exclusive, non‑transferable, non‑assignable, revocable, royalty‑free license to use, reproduce, and publish the Assets in any online and offline materials in accordance with the following terms and conditions ("License").

2. You shall call to the attention of Sanofi US any possible infringement, fraud, or misrepresentation involving the trademark Auvi-Q or the Assets. Sanofi US, its affiliates, and/or related companies, as the case may be, shall have sole discretion to act to prevent any infringement, fraud, or misrepresentation involving Auvi‑Q or the Assets and You hereby agree to cooperate fully to any such act.

3. Subject to the restrictions provided herein, You may (a) download and/or embed and incorporate, publish and distribute the Assets into your own professional works and (b) use the Assets only in accordance with this agreement or subject to the prior written approval of Sanofi US.

4. In using the Assets, You agree that you will not (a) modify or alter them in any way, (b) create scandalous, obscene, defamatory, immoral or unethical materials or use, (c) use them in association with any discriminatory content, (d) do anything to mislead the public as to the nature or quality of the product on which the trade‑mark Auvi‑Q and the Assets are affixed, (e) use the Assets in any manner whatsoever that may jeopardize their significance, distinctiveness, or validity, or (f) use them for any other purpose than as permitted in this agreement or for any purpose which is prohibited by law.

5. This License shall remain in effect until terminated. It will be terminated immediately if You fail to comply with any of these terms or conditions. In addition, Sanofi US may terminate this License at any time for any reason whatsoever. Any such termination will not entitle you to any compensation or remuneration from Sanofi US. Upon termination, You shall immediately 1) cease to use the Assets or 2) destroy or return to Sanofi US all copies of the Assets.

6. This License shall be governed by the laws of the State of New Jersey and is limited to use of the Assets within the United States.

Cancel

Terms & Conditions

The following terms of use apply to your use of the Auvi-Q™ (epinephrine injection, USP) video(s) ("Assets").

1. Sanofi US, on behalf of itself and its affiliates, hereby grants to you ("You") a non‑exclusive, non‑transferable, non‑assignable, revocable, royalty‑free license to use, reproduce, and publish the Assets in any online and offline materials in accordance with the following terms and conditions ("License").

2. You shall call to the attention of Sanofi US any possible infringement, fraud, or misrepresentation involving the trademark Auvi-Q or the Assets. Sanofi US, its affiliates, and/or related companies, as the case may be, shall have sole discretion to act to prevent any infringement, fraud, or misrepresentation involving Auvi‑Q or the Assets and You hereby agree to cooperate fully to any such act.

3. Subject to the restrictions provided herein, You may (a) download and/or embed and incorporate, publish and distribute the Assets into your own professional works and (b) use the Assets only in accordance with this agreement or subject to the prior written approval of Sanofi US.

4. In using the Assets, You agree that you will not (a) modify or alter them in any way, (b) create scandalous, obscene, defamatory, immoral or unethical materials or use, (c) use them in association with any discriminatory content, (d) do anything to mislead the public as to the nature or quality of the product on which the trade‑mark Auvi‑Q and the Assets are affixed, (e) use the Assets in any manner whatsoever that may jeopardize their significance, distinctiveness, or validity, or (f) use them for any other purpose than as permitted in this agreement or for any purpose which is prohibited by law.

5. This License shall remain in effect until terminated. It will be terminated immediately if You fail to comply with any of these terms or conditions. In addition, Sanofi US may terminate this License at any time for any reason whatsoever. Any such termination will not entitle you to any compensation or remuneration from Sanofi US. Upon termination, You shall immediately 1) cease to use the Assets or 2) destroy or return to Sanofi US all copies of the Assets.

6. This License shall be governed by the laws of the State of New Jersey and is limited to use of the Assets within the United States.

Cancel
SEE MORE

Indication

Auvi‑Q™ (epinephrine injection, USP) is indicated in the emergency treatment of allergic reactions (Type I) including anaphylaxis to allergens, idiopathic and exercise-induced anaphylaxis. Auvi‑Q is intended for individuals with a history of anaphylaxis or who are at risk for anaphylactic reactions.

Important Safety Information

Auvi‑Q should ONLY be injected into the anterolateral aspect of the thigh. DO NOT INJECT INTO BUTTOCK OR INTRAVENOUSLY.

Epinephrine should be administered with caution to patients with certain heart diseases, and in patients who are on medications that may sensitize the heart to arrhythmias, because it may precipitate or aggravate angina pectoris and produce ventricular arrhythmias. Arrhythmias, including fatal ventricular fibrillation, have been reported in patients with underlying cardiac disease or taking cardiac glycosides or diuretics. Patients with certain medical conditions or who take certain medications for allergies, depression, thyroid disorders, diabetes, and hypertension, may be at greater risk for adverse reactions. Adverse reactions to epinephrine include anxiety, apprehensiveness, restlessness, tremor, weakness, dizziness, sweating, palpitations, pallor, nausea and vomiting, headache, and/or respiratory difficulties.

Auvi‑Q is intended for immediate self-administration as emergency supportive therapy only and is not a substitute for immediate medical or hospital care.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see full Prescribing Information.

References | Site Map | FAQs

© 2002-2014 sanofi-aventis U.S. LLC. All rights reserved.
Legal Disclaimer Information and Privacy Policy
Questions or Comments? Click here to contact us.
This site is intended for use by U.S. Healthcare Professionals only.
US.EAI.13.10.037 Last Update: January 2014

You Are About to Leave a Sanofi US Web Site

Please note:

By clicking on this link, you will be leaving this Sanofi US Web site and going to another, entirely independent, Web site. Sanofi US provides these links as a service to its Web site visitors and users; however, it takes no responsibility for the information on any Web site but its own.

Click the "Continue" button below to go to the page you requested or click "Cancel" to remain on the page.

Cancel